Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort

Multicystic peritoneal mesothelioma treated with cytoreductive surgery followed or not by hyperthermic intraperitoneal chemotherapy: results from a large multicentric cohort

Background Multicystic peritoneal mesothelioma (MCPM) is a rare, slowly growing, condition prone to recur after surgery. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) added to complete cytoreductive surgery (CRS) remains controversial and difficult to assess. As patients are mostly r...

Full description

Bibliographic Details
Main Authors: Vahan Kepenekian, Julien Péron, Diane Goéré, Olivia Sgarbura, Jean-Baptiste Delhorme, Clarisse Eveno, Nazim Benzerdjeb, Isabelle Bonnefoy, Laurent Villeneuve, Pascal Rousset, Karine Abboud, Marc Pocard, Olivier Glehen, On Behalf RENAPE (French Network for Rare Peritoneal Malignancies)
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:International Journal of Hyperthermia
Subjects:
multicystic mesothelioma
cytoreductive surgery
crs
hyperthermic intraperitoneal chemotherapy
hipec
fertility
Online Access:http://dx.doi.org/10.1080/02656736.2021.1903585

Internet

http://dx.doi.org/10.1080/02656736.2021.1903585

Similar Items